Sackler Trust grants: UK charities kept unnamed

Published: 02 January 2026. The English Chronicle Desk. The English Chronicle Online.

Two British charities that received more than £1.1m in Sackler Trust grants were deliberately kept anonymous, according to newly filed accounts. Trustees said disclosure could cause serious prejudice, risking reputational damage that might undermine charitable work. The decision has reignited scrutiny of Sackler Trust grants and their ethical implications across Britain’s charitable landscape.

The Sackler Trust, funded by wealth linked to the US opioid crisis, distributed £3.8m during 2024. Arts, education, and science organisations benefited, according to accounts submitted on New Year’s Eve. While most recipients were listed, two charities receiving a combined £1.15m were omitted entirely. Trustees argued anonymity was essential to protect those organisations from potential backlash.

Concerns surrounding Sackler Trust grants are not new. Many cultural institutions distanced themselves years ago from the Sackler name. The association with Purdue Pharma, the company behind OxyContin, has proved damaging. OxyContin’s aggressive marketing contributed to widespread addiction and loss of life across the United States. That legacy continues to shadow philanthropic efforts tied to the family fortune.

The accounts stated that naming certain recipients would expose them to serious prejudice. Trustees added that such exposure could impair the furtherance of charitable activities. This wording mirrors explanations used in previous years, suggesting a consistent policy of selective disclosure. Critics argue the practice limits transparency while shielding beneficiaries from public scrutiny.

Among the named recipients of Sackler Trust grants were Veterans Aid and the Belvoir Cricket and Countryside Trust. Each received £250,000 during 2024. Veterans Aid works with former service personnel facing homelessness and hardship. The Belvoir trust focuses on countryside education and promoting sport, particularly cricket, among young people.

Other organisations receiving significant funding included community and rehabilitation charities across England. Happy Day Ministries, the Peterborough Asylum and Refugee Community Association, and the Waterlife Recovery Trust each received notable sums. Additional beneficiaries included Cliftonville Community Centre, Inside Job, Living Room, Mustard Tree, and Not Beyond Redemption.

In total, the trust issued 98 grants during 2024, a sharp increase from 69 the previous year. Commitments reached £7.4m by year’s end, including funds carried forward. These figures underline the scale of Sackler Trust grants, despite claims that the trust paused new donations several years ago.

In 2019, trustees publicly announced a halt to new giving. The move followed growing protests against institutions accepting Sackler-linked funding. However, accounts reveal that grant-making quietly resumed in 2020. Since then, annual filings have continued to show substantial distributions, alongside exemptions for unnamed recipients.

The Sackler Trust remains chaired by Dame Theresa Sackler. She served on the Purdue Pharma board from 1993 until 2018. She is the widow of Mortimer Sackler, one of the three brothers who built Purdue into a pharmaceutical powerhouse. Her children, Michael, Marissa, and Sophia Sackler, also serve as trustees.

The family charity holds assets valued at approximately £50m. Over decades, Sackler Trust grants supported galleries, universities, and research institutions. Yet the family’s philanthropic image shifted dramatically following investigative reporting into Purdue’s practices. Campaigners accused the Sacklers of prioritising profit over patient safety.

As pressure mounted, major British cultural institutions severed ties. The National Gallery, National Portrait Gallery, Royal Opera House, Shakespeare’s Globe, and Tate all rejected Sackler funding. Some returned donations or removed the Sackler name from galleries. These decisions reflected growing public discomfort around accepting money linked to the opioid epidemic.

The term “reputation laundering” has often been used by critics describing Sackler Trust grants. They argue philanthropy was deployed to soften public perception while legal battles intensified. Supporters counter that charities should not be penalised for accepting funds directed toward social good, particularly when grants address urgent needs.

The US legal context continues to shape debate. In November, a federal judge indicated he would approve Purdue Pharma’s latest settlement plan. The agreement aims to resolve thousands of lawsuits related to opioid harm. Under the deal, members of the Sackler family would contribute up to $7bn and relinquish company ownership.

The proposed settlement includes funds earmarked for addiction treatment and victim compensation. While some see it as accountability, others view it as insufficient given the scale of harm. Nevertheless, the agreement could mark the end of years of litigation that further damaged the Sackler name.

Against this backdrop, Sackler Trust grants in the UK attract renewed attention. Transparency campaigners argue anonymity undermines accountability. They question whether charities should accept funding that requires concealment. Others stress that refusing such money could deprive vulnerable communities of essential support.

The trust maintains that discretion protects beneficiaries from unfair stigma. Trustees insist decisions are made to further charitable purposes, not obscure wrongdoing. They emphasise that grants are allocated independently of Purdue’s operations, despite shared family links.

Dame Theresa Sackler previously expressed sadness over the American addiction crisis. In a statement issued when giving was paused, she supported Purdue’s efforts to address harm. She also rejected allegations made against the company and certain family members. That stance continues to divide opinion.

For unnamed charities, anonymity may provide temporary protection. However, questions persist about long-term trust in the charitable sector. Public confidence relies heavily on openness, especially when funds originate from controversial sources. The balance between pragmatism and principle remains delicate.

As Sackler Trust grants continue, scrutiny is unlikely to fade. Annual accounts will be examined closely by regulators, journalists, and campaigners alike. Whether greater transparency emerges may depend on evolving public expectations and legal frameworks.

For now, the omission of two charities from official records highlights enduring tensions. Philanthropy, ethics, and accountability intersect uneasily when wealth is entwined with suffering. The debate surrounding Sackler Trust grants shows no sign of resolution.

Check our latest news